GALE — Galenica AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Galenica AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,835	3,588	3,746	3,921	4,136
Cost of Revenue
Gross Profit	968	985	1,042	1,087	1,156
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,627	3,395	3,547	3,707	3,903
Operating Profit	207	193	199	214	232
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	203	190	195	215	222
Provision for Income Taxes
Net Income After Taxes	168	157	166	184	184
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	168	165	285	183	181
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	168	165	285	183	181
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.22	3.13	3.29	3.61	3.66
Dividends per Share